Drug
Cosibelimab
Cosibelimab: highest development phase Phase 1, developed by TG Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- TG Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Cosibelimab NCT03778073 | Phase 1 | B-cell Non Hodgkin Lymphoma |
Latest
No recent events.
Follow Cosibelimab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.